Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model. Alzheimer's & Dementia: Translational Research & Clinical Interventions, Volume 4, 2018, Pages 488-498.
Glucocorticoid Induced Leucine Zipper in Lipopolysaccharide Induced Neuroinflammation. Front Aging Neurosci. 2019 Jan 25;10:432.
Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease. Mol Neurobiol. 2017;54(10):8063–8070.
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis:
Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells. PLoS One. 2016;11(10):e0160314.
Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation:
CD80 Blockade Enhance Glucocorticoid-Induced Leucine Zipper Expression and Suppress Experimental Autoimmune Encephalomyelitis: